FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093583314> ?p ?o ?g. }

• W2093583314 endingPage "975" @default.
• W2093583314 startingPage "967" @default.
• W2093583314 abstract "Toxicity-reduced conditioning is a curative treatment option for medically compromised or elderly patients ineligible for myeloablative hematopoietic cell transplantation (HCT). The aim of this study was to detect prognostic factors for overall survival (OS) and to evaluate quality of life (QOL) in a large homogeneous cohort of 160 consecutive patients aged > or =60 years treated with allogeneic HCT. We evaluated age, sex, performance status, comorbidities, pulmonary function, lactic dehydrogenase concentration, type of donor, disease status, CD34(+) cells transplanted, cytomegalovirus status, time from diagnosis to HCT, and the development of acute and chronic graft-versus-host disease (GVHD). All patients who survived for > or =6 months (n = 79) were asked to complete a QOL survey. All patients (median age, 64.7 years; range, 60.1-76 years) received pretransplantation conditioning with fludarabine, BCNU, and melphalan. With a median follow-up of 35 months, the 1-year OS was 62.4% and 3-year OS was 47.4%. Multivariate analysis revealed compromised performance status as the most significant negative prognostic parameter for OS (P < .003), whereas male donor (P = .008) and chronic GVHD (P = .024) were associated with better OS. The 89% of survivors who returned the QOL questionnaire rated their global QOL as good-to-excellent despite impaired functional capabilities and such symptoms as fatigue, dyspnea, and loss of appetite. The main prognostic factor was performance status, not age. Our data suggest that toxicity-reduced conditioning offers a chance for enhanced OS with an adequate QOL." @default.
• W2093583314 created "2016-06-24" @default.
• W2093583314 creator A5000979538 @default.
• W2093583314 creator A5023417817 @default.
• W2093583314 creator A5035666187 @default.
• W2093583314 creator A5074339903 @default.
• W2093583314 creator A5080642891 @default.
• W2093583314 creator A5084494517 @default.
• W2093583314 creator A5088238455 @default.
• W2093583314 date "2010-07-01" @default.
• W2093583314 modified "2023-09-27" @default.
• W2093583314 title "Prognostic Factor and Quality of Life Analysis in 160 Patients Aged ≥60 Years with Hematologic Neoplasias Treated with Allogeneic Hematopoietic Cell Transplantation" @default.
• W2093583314 cites W1487950379 @default.
• W2093583314 cites W1530764705 @default.
• W2093583314 cites W1947168884 @default.
• W2093583314 cites W1973402603 @default.
• W2093583314 cites W1974938631 @default.
• W2093583314 cites W1979091618 @default.
• W2093583314 cites W1987551916 @default.
• W2093583314 cites W1995569130 @default.
• W2093583314 cites W1999533140 @default.
• W2093583314 cites W2003641238 @default.
• W2093583314 cites W2003959626 @default.
• W2093583314 cites W2012538864 @default.
• W2093583314 cites W2016289906 @default.
• W2093583314 cites W2021727607 @default.
• W2093583314 cites W2022015347 @default.
• W2093583314 cites W2022768792 @default.
• W2093583314 cites W2022794150 @default.
• W2093583314 cites W2026312325 @default.
• W2093583314 cites W2026625631 @default.
• W2093583314 cites W2027426882 @default.
• W2093583314 cites W2027758287 @default.
• W2093583314 cites W2032541332 @default.
• W2093583314 cites W2033433258 @default.
• W2093583314 cites W2034295250 @default.
• W2093583314 cites W2040041834 @default.
• W2093583314 cites W2043133976 @default.
• W2093583314 cites W2047179093 @default.
• W2093583314 cites W2047820848 @default.
• W2093583314 cites W2051541634 @default.
• W2093583314 cites W2054837595 @default.
• W2093583314 cites W2055086852 @default.
• W2093583314 cites W2062871466 @default.
• W2093583314 cites W2063803441 @default.
• W2093583314 cites W2081345844 @default.
• W2093583314 cites W2086335950 @default.
• W2093583314 cites W2093679650 @default.
• W2093583314 cites W2101672163 @default.
• W2093583314 cites W2102443829 @default.
• W2093583314 cites W2103232061 @default.
• W2093583314 cites W2106246606 @default.
• W2093583314 cites W2116976533 @default.
• W2093583314 cites W2117550229 @default.
• W2093583314 cites W2120756704 @default.
• W2093583314 cites W2123711386 @default.
• W2093583314 cites W2128812336 @default.
• W2093583314 cites W2139436147 @default.
• W2093583314 cites W2148047805 @default.
• W2093583314 cites W2159738043 @default.
• W2093583314 cites W2161518550 @default.
• W2093583314 cites W2167571044 @default.
• W2093583314 cites W2229509524 @default.
• W2093583314 cites W2233401455 @default.
• W2093583314 cites W2315338268 @default.
• W2093583314 cites W2318980714 @default.
• W2093583314 cites W45351630 @default.
• W2093583314 doi "https://doi.org/10.1016/j.bbmt.2010.02.004" @default.
• W2093583314 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20144720" @default.
• W2093583314 hasPublicationYear "2010" @default.
• W2093583314 type Work @default.
• W2093583314 sameAs 2093583314 @default.
• W2093583314 citedByCount "46" @default.
• W2093583314 countsByYear W20935833142012 @default.
• W2093583314 countsByYear W20935833142013 @default.
• W2093583314 countsByYear W20935833142014 @default.
• W2093583314 countsByYear W20935833142015 @default.
• W2093583314 countsByYear W20935833142016 @default.
• W2093583314 countsByYear W20935833142017 @default.
• W2093583314 countsByYear W20935833142018 @default.
• W2093583314 countsByYear W20935833142019 @default.
• W2093583314 countsByYear W20935833142020 @default.
• W2093583314 countsByYear W20935833142022 @default.
• W2093583314 countsByYear W20935833142023 @default.
• W2093583314 crossrefType "journal-article" @default.
• W2093583314 hasAuthorship W2093583314A5000979538 @default.
• W2093583314 hasAuthorship W2093583314A5023417817 @default.
• W2093583314 hasAuthorship W2093583314A5035666187 @default.
• W2093583314 hasAuthorship W2093583314A5074339903 @default.
• W2093583314 hasAuthorship W2093583314A5080642891 @default.
• W2093583314 hasAuthorship W2093583314A5084494517 @default.
• W2093583314 hasAuthorship W2093583314A5088238455 @default.
• W2093583314 hasBestOaLocation W20935833141 @default.
• W2093583314 hasConcept C121608353 @default.
• W2093583314 hasConcept C126322002 @default.
• W2093583314 hasConcept C141071460 @default.
• W2093583314 hasConcept C143998085 @default.
• W2093583314 hasConcept C159110408 @default.

• next